Search Results 7781-7790 of 26262 for oral

  1. Publications - Maryam Mahmood, M.B., Ch.B. - Mayo Clinic

    Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in ...

  2. Obstructive sleep apnea - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Sleep Medicine in Minnesota · Sleep Medicine · Sleep Surgery Clinic ...

  3. Salivary gland tumors - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...

  4. A Phase I/II, open-label, multi-center trial of [177Lu]Lu-NeoB in combination with capecitabine in adult patients with GRPR+, ER+, HER2- metastatic breast cancer after progression on previous endocrine therapy in combination with a CDK4/6 inhibito - Mayo Clinic

    Note: Use of oral (estrogen and progesterone), injected or implanted hormonal methods of contraception or intrauterine system (IUS) or any other form of ...

  5. Obstructive sleep apnea - Doctors and departments - Mayo Clinic

    Departments that treat this condition. Dental Specialties · Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Sleep ...

  6. Student Stories - Nuclear Medicine Technology Program (Minnesota)

    Learn more about what our graduates have gone to accomplish after graduating from the Nuclear Technology Program at Mayo Clinic in Rochester, Minnesota.

  7. Coronary Artery Disease Clinical Trials - Mayo Clinic Research

    ... oral daily rapamycin (0.5, 1, and 2mg) dose for the duration of CR. Baseline and follow-up data will be collected for age-associated impairment (AAI): ...

  8. Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer - Mayo Clinic

    Major surgery within 28 days before starting trial therapy. 8. Inability to take oral medications, refractory or chronic nausea, gastrointestinal conditions ...

  9. Advancing science through medical education - Mayo Clinic

    Garica presented the study results as an oral presentation at CHEST 2023 in Hawaii. "These findings may inform the development of standardized operating ...

  10. Expert Alert: Mayo Clinic expert shares tips for good outcomes after hip, knee replacement surgery

    Rhoda Madson, Mayo Clinic Public Affairs, newsbureau@mayo.edu · Mayo Clinic Q&A podcast: Advances in oral cancer treatment, reconstruction · Low-dose aspirin to ...